Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 566 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Vaginal Diseases Clear all

Conditions: Ovary Cancer, Endometrial Cancer, Uterine Cancer, Cervical Cancer, Cervix Cancer, Vulvar Cancer, Vaginal Cancer
Interventions: Fit4Treatment; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 60 Years and older · Female only
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Intrauterine Fetal Demise, Fetal Death
Interventions: Mifepristone, placebo; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 16 Years and older · Female only
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Delivery Problem, Cervix; Pregnancy, Pregnancy Related
Interventions: cervical exam training; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: Not listed
Enrollment: 1,125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Cancer
Interventions: Fentanyl sublingual spray, Placebo; Drug
Lead sponsor: INSYS Therapeutics Inc; Industry
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Chandler, Arizona

Conditions: Endometriosis
Interventions: Active treatment with a high dose of BGS649, Active treatment with a low dose of BGS649, Placebo treatment to blind study; Drug
Lead sponsor: Mereo BioPharma; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Anaheim, California

Conditions: Vaginal Cancer
Interventions: Magnetic Resonance Imaging (MRI), Diffusion Weighted Magnetic Resonance Imaging (DWMR); Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hemorrhoids
Interventions: Hem-Avert Perianal Stabilizer; Device
Lead sponsor: Stetrix, Inc.; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 3
States / cities: Southaven, Mississippi • Covington, Tennessee • Memphis, Tennessee

Conditions: HIV Infections
Interventions: Dapivirine Vaginal Ring, Maraviroc Vaginal Ring, Placebo Vaginal Ring, Dapivirine-Maraviroc Vaginal Ring; Drug · Other
Lead sponsor: International Partnership for Microbicides, Inc.; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 3
States / cities: Birmingham, Alabama • Boston, Massachusetts • Pittsburgh, Pennsylvania

Conditions: HIV Infections
Interventions: BufferGel, PRO 2000/5 Gel, Placebo gel; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 3,101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Vaginitis Trichomonal or Due to Trichomonas
Interventions: MTZ 500 mg twice daily x 7 days, MTZ 2 g; Drug
Lead sponsor: Tulane University Health Sciences Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 623 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 3
States / cities: Birmingham, Alabama • New Orleans, Louisiana • Jackson, Mississippi

Conditions: Bacterial Vaginosis, Candida Vaginitis
Interventions: cobas® BV/CV test, BD Max™ Vaginal Panel, Cepheid Xpert Xpress MVP, Hologic Aptima BV Assay; Diagnostic Test
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 14 Years and older · Female only
Enrollment: 738 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 8
States / cities: Los Angeles, California • San Diego, California • Lakewood, Colorado + 5 more

Conditions: Vaginosis, Bacterial
Interventions: Metronidazole Gel; Drug
Lead sponsor: Insud Pharma; Industry
Eligibility: 12 Years to 17 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 8
States / cities: Long Beach, California • Paramount, California • Bardstown, Kentucky + 5 more

Conditions: HIV Infections
Interventions: Chlorhexidine gluconate; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: Not listed
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Ends 2007
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Menopausal and Perimenopausal Disorder, Unspecified, Atrophic Vaginitis
Interventions: Vaginal Lubrication Ring for Vaginal Dryness; Device
Lead sponsor: J3 Bioscience, Inc.; Industry
Eligibility: 35 Years and older · Female only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Hiv, HSV
Interventions: TAF/EVG Vaginal Insert; Drug
Lead sponsor: CONRAD; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Abnormal Uterine Bleeding, Uterine Bleeding, Fibroid Uterus, Surgery
Interventions: Total Laparoscopic Hysterectomy; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Microbiome, Antibiotic-Induced VVC, Vaginal Candidiasis
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Bacterial Vaginosis
Interventions: Trimo-San gel; Drug
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older · Female only
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Albuquerque, New Mexico

Conditions: Recurrent Bacterial Vaginosis
Interventions: Secnidazole 2 GM Oral Granules; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Cancer
Interventions: aminocamptothecin colloidal dispersion; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1998
U.S. locations: 1
States / cities: New York, New York

Conditions: Vulvar Dysplasia, Vaginal Dysplasia
Interventions: CO2 laser surgery, ultrasonic surgical aspiration; Procedure
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2005
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Childbirth
Interventions: Materna Prep Device, Sham Control; Device
Lead sponsor: Materna Medical; Industry
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Mountain View, California

Conditions: Human Papilloma Virus, Cervical Cancer, Human Papillomavirus Infection, Oropharyngeal Cancer, Vaginal Cancer, Vulvar Cancer, Anal Cancer, Penile Cancer
Interventions: WoW and BNI; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 9 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma, Endometrial Carcinoma, Malignant Female Reproductive System Neoplasm, Ovarian Carcinoma, Ovarian Carcinosarcoma, Stage III Cervical Cancer AJCC v8, Stage III Vaginal Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8, Stage IV Cervical Cancer AJCC v8, Stage IV Vaginal Cancer AJCC v8, Stage IV Vulvar Cancer AJCC v8, Triple-Negative Breast Carcinoma, Uterine Corpus Carcinosarcoma
Interventions: Best Practice, Interview, Supportive Care, Survey Administration, Telephone-Based Intervention; Other · Behavioral
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 11
States / cities: Arcadia, California • Duarte, California • Huntington Beach, California + 8 more

Search by objective public record fields.

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Mifepristone Induction for Fetal Demise

Effects of Systematic Cervical Exam Training on Labor and Delivery Care

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

BGS649 Monotherapy in Moderate to Severe Endometriosis Patients

Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina

Prevention and/or Reduction of Hemorrhoids and/or Thrombosed External Hemorrhoids Using the HEM-AVERT Perianal Stabilizer Instrument

Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring

BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women

Trichomonas Vaginalis Repeat Infections Among HIV Negative Women

Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis

Safety and Tolerability of Metronidazole Gel 1.3%

A Study of Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies

Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness

Safety, PK, and PD Study of a Vaginal Insert Containing TAF and EVG

Outcomes on Abdominal Versus Vaginal Morcellation At Time of Hysterectomy

Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women

Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis

Suppressive Antibacterial Therapy With Once-Weekly Secnidazole Granules to Prevent Recurrent Bacterial Vaginosis; A Pilot Study

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia

A Clinical Phase II Study of the Materna Device to Shorten Delivery Time During Childbirth

Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer